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Abstract
If copy number variants (CNVs) are predominantly deleterious, we would expect them to bemore efficiently purged from
populations with a large effective population size (Ne) than from populations with a small Ne. Malaria parasites
(Plasmodium falciparum) provide an excellent organism to examine this prediction, because this protozoan shows a
broad spectrum of population structures within a single species, with large, stable, outbred populations in Africa, small
unstable inbred populations in South America and with intermediate population characteristics in South East Asia. We
characterized 122 single-clone parasites, without prior laboratory culture, from malaria-infected patients in seven
countries in Africa, South East Asia and South America using a high-density single-nucleotide polymorphism/CNV
microarray. We scored 134 high-confidence CNVs across the parasite exome, including 33 deletions and 102 amplifica-
tions, which ranged in size from <500bp to 59kb, as well as 10,107 flanking, biallelic single-nucleotide polymorphisms.
Overall, CNVs were rare, small, and skewed toward low frequency variants, consistent with the deleterious model.
Relative to African and South East Asian populations, CNVs were significantly more common in South America,
showed significantly less skew in allele frequencies, and were significantly larger. On this background of low frequency
CNV, we also identified several high-frequency CNVs under putative positive selection using an FST outlier analysis. These
included known adaptive CNVs containing rh2b and pfmdr1, and several other CNVs (e.g., DNA helicase and three
conserved proteins) that require further investigation. Our data are consistent with a significant impact of genetic
structure on CNV burden in an important human pathogen.
Key words: copy number variation, population genetics, parasitology.
Introduction
Copy number variation (CNV) is widespread in eukaryotic
genomes, in taxa ranging from yeast (Liti et al. 2009) to
humans (Mills et al. 2011) and multiple organisms in between
(Emerson et al. 2008; Brown et al. 2012). The selective forces
determining the distribution of CNVs within populations are
poorly understood. Several clear examples of the beneficial
nature of CNVs exist. For instance, amplification of the
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CCL3L1 gene lowers risk of HIV progression (Gonzalez et al.
2005), and amylase copy number correlates with dietary
starch levels in both humans (Perry et al. 2007) and domes-
ticated dogs (Axelsson et al. 2013). However, there is accu-
mulating evidence that CNV may be generally deleterious and
subject to purifying selection. This notion has several lines of
support; 1) the size spectrum of CNVs is skewed toward
smaller variants, consistent with the expectation that longer
variants tend to have a greater impact on fitness. 2) The allele
frequency spectrum of CNVs is generally skewed toward rare
variants (Conrad et al. 2010; Mills et al. 2011; Sjodin and
Jakobsson 2012). Additionally, coding regions of the
genome show lower levels of CNV than noncoding regions
(Conrad et al. 2010) because structural variation within
coding sequence has a greater potential to be deleterious.
This may result from disruption of gene function due to
truncations, frameshifts, duplications, or deletions.
If CNVs are typically deleterious, we expect that the burden
of CNVs will scale inversely with the effective population size
(Ne), because the strength of purifying selection is strongest in
large populations (Ohta 1992). Under this model, populations
with large Ne will contain a lower burden of CNVs than pop-
ulations with small Ne, because large populations can purge
deleterious mutations more effectively than small popula-
tions. This has been suggested as an explanation for the dif-
ferences in CNV burden between great ape species (Gazave
et al. 2011; Sudmant et al. 2013): western chimpanzees show
low nucleotide diversity consistent with a population bottle-
neck (Prado-Martinez et al. 2013) but also show significantly
higher levels of both segregating and fixed deletions than
other great ape lineages. Supporting evidence also comes
from the comparison of three model eukaryotes
(Saccharomyces cerevisiae, Drosophila melanogaster and
Caenorhabditis elegans) for which estimated Ne are 3.3 
107, 1.15  106, and 8  104, respectively, and for which
CNV mutation rates have been directly measured by muta-
tion accumulation experiments and calculated bioinformati-
cally from sequence data by measuring the age distribution of
gene duplicates (Katju and Bergthorsson 2013). The bioinfor-
matic approach provided estimates 36,000-fold lower than
predicted from mutation accumulation experiments for
yeast suggesting strong selection against new duplications,
but the discrepancy is much lower for D. melanogaster
(660-fold) and C. elegans (340-fold) which have lower Ne.
Both great ape and model organism comparisons rely on
comparisons between species so are potentially confounded
by other differences between these species. Malaria parasites
provide a useful system for directly investigating the relation-
ship between genetic parameters of a population (i.e., recom-
bination rate, inbreeding rate, and Ne) and CNV, because this
protozoan shows a broad spectrum of population structures
within a single species (Anderson et al. 2000; Manske et al.
2012). These range from small, unstable, inbred populations
with low recombination rates in South America, to large,
outbred populations with very high recombination rates in
Africa (Anderson et al. 2000; Joy et al. 2003; Neafsey et al. 2008;
Manske et al. 2012). For example, there is a 10–24-fold differ-
ence in Ne (Anderson et al. 2000; Joy et al. 2003) and 4 250-
fold difference in the population scaled recombination rate
(Mu et al. 2005) between African and South American para-
site populations. These differences have been repeatedly con-
firmed using mitochondrial DNA and single-nucleotide
polymorphism (SNP) and microsatellite analyses of nuclear
polymorphisms (Anderson et al. 2000; Joy et al. 2003; Mu et al.
2005; Neafsey et al. 2008). These diversity-based measures
parallel differences in census population size in contemporary
parasite populations, with an estimated 122 million P. falcip-
arum cases in Africa, 3 million in SE Asia, and 0.4 million in
South America (World Health Organization 2014). The cen-
tral goal of this project was to compare the impact of Ne (and
associated population parameters) on copy number dynam-
ics in a single species, rather than relying on cross species
comparisons.
There have been several previous surveys of CNV in P.
falciparum (Carret et al. 2005; Kidgell et al. 2006; Ribacke
et al. 2007; Jiang et al. 2008; Cheeseman et al. 2009;
Mackinnon et al. 2009). However, these previous studies
have two limitations. First, these studies have used parasite
isolates that were grown in cell culture media in the labora-
tory, to ensure sufficient DNA for analysis. This is not ideal
because CNVs are known to emerge extremely rapidly during
laboratory selection. For instance, large chromosomal trunca-
tions have been frequently observed following initiation of
parasite cultures (Biggs et al. 1989; Shirley et al. 1990; Kemp
et al. 1992) or between isogenic clones (Carret et al. 2005) and
amplification of the Rh1 gene is observed in 30–40% of labor-
atory lines though has yet to be observed in field isolates
(Nery et al. 2006; Jennings et al. 2007; Mackinnon et al.
2009; Nair et al. 2010). Second, the numbers of parasites ex-
amined in previous studies were modest, ranging from two
(Carret et al. 2005) to 16 (Cheeseman et al. 2009), precluding
rigorous comparisons between parasite populations.
Consequently, another goal of this work was to describe
the CNV landscape in a global sample of natural P. falciparum
population obtained directly from the blood of patients to
avoid bias resulting from adaptation to laboratory culture.
Prior genome-wide investigations of CNV in the P. falcip-
arum genome have suggested that a large proportion of the
parasite genome (~5%) exhibits CNV (Carret et al. 2005;
Kidgell et al. 2006; Ribacke et al. 2007; Jiang et al. 2008;
Cheeseman et al. 2009; Mackinnon et al. 2009). There has
been considerable success in linking CNVs detected in these
studies to clinically relevant phenotypes. Notably, detection
of gene amplification at GTP-cyclohydrolase (Kidgell et al.
2006), a key enzyme in the folate biosynthesis pathway,
prompted further characterization of this mutation in field
lines (Nair et al. 2008) and through experimental manipula-
tion in the laboratory (Heinberg et al. 2013). These studies
suggest that this CNV contributes to the genetic robustness
of anti-folate resistance evolution (Kumpornsin et al. 2014).
CNVs are involved in other clinically relevant phenotypic
traits including mefloquine resistance (Cowman et al. 1994),
erythrocyte invasion (Triglia et al. 2005), and cytoadhence/
gametocytogenesis (Biggs et al. 1989; Shirley et al. 1990; Kemp
et al. 1992) and affect gene expression both locally and distally
within the genome (Gonzales et al. 2008; Mackinnon et al.
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2009). The breakpoints of CNV regions are preferentially lo-
cated in A/T-rich regions or homopolymeric tracts (Nair et al.
2007; Guler et al. 2013). Given that the P. falciparum genome
is strongly AT biased (85% AT (Gardner et al. 2002), that
homopolymeric AT tracts are extremely common, and that
over 1011 parasites are found within infected patients, CNVs
are predicted to be a major source of adaptive polymorphism
(Nair et al. 2007; Guler et al. 2013). This supposition is strongly
supported by laboratory selection experiments with P. falcip-
arum. Numerous studies, using selection with different anti-
malarial drugs, reveal amplification in specific genome regions
containing target resistance genes (Thaithong et al. 2001;
Singh and Rosenthal 2004; Dharia et al. 2009; Eastman et al.
2011) and this approach is now routinely used to identify
genome regions targeted by new drugs (Flannery et al.
2013). While CNV clearly occurs commonly in the laboratory,
with duplication rates estimated at approximately 107 per
genome per 48-h asexual cycle for two individual loci
(Preechapornkul et al. 2009; Guler et al. 2013), there is a
clear need to understand how the spread of beneficial
CNVs shapes the malaria parasite genome. A third goal of
this study was to identify CNVs that play a role in adaptive
evolution of parasites in natural parasite populations.
We examined 122 uncultured, geographically dispersed,
malaria parasite isolates containing a single predominant
clone using a custom SNP/CGH array (Tan et al. 2011), iden-
tifying 134 high-confidence CNVs within the exome and gen-
otyping 10,107 flanking, biallelic SNPs with a global minor
allele frequency 1%. We used the data to 1) compare
CNV distribution and size from across the spectrum of pop-
ulation structures observed in P. falciparum, 2) to jointly ex-
amine both CNV and SNP variation allowing comparison of
population genetics at these different variants, and 3) to de-
termine geographical variation in CNVs to identify variants
that may be adaptive and functionally important.
Results
Parasite Samples
We excluded P. falciparum-infected blood samples containing
multiple genotype infections (supplementary table S1,
Supplementary Material online), because these complicate
scoring of SNPs and CNV and preclude construction of
parasite haplotypes. In low-transmission locations, where
self-fertilization of parasites commonly occurs, genetically
indistinguishable parasites are frequently found in different
patients (Anderson et al. 2000, 2010; Echeverry et al. 2013).
We included a single representative of each multilocus geno-
type identified from preliminary genotyping data to avoid
oversampling identical or very closely related parasites.
Hence, the final set of 157 parasite samples included in the
study comprised genetically unique infections containing a
single predominant genotype. The preliminary genotyping
data illustrate the differences in genetic structure between
populations (Anderson et al. 2000). We see high levels of
multiple genotype infections and no identical multilocus ge-
notypes in African sites. In contrast in South American loca-
tions, there is very little multiple-clone infection, and only 13
independent genotypes were found among the 81 blood sam-
ples examined. These trends are consistent with previous
analysis of global population structure in P. falciparum
(Anderson et al. 2000). Inference of global and local popula-
tion structure is supported by principal component analysis
of 10,107 SNPs typed in each of the 122 samples used in the
final analysis. The continent and country of origin of each
isolate is well captured, with African, South East Asian, and
South American isolates forming distinct clusters (supple-
mentary fig. S1, Supplementary Material online).
Robust Determination of Copy Number Variation
The P. falciparum genome, which is 4 80% AT-rich and in-
cludes nonexonic intervals entirely devoid of C/G residues
(Gardner et al. 2002), provides a challenge for CGH-based
detection of CNV. We took several steps to ensure the reli-
ability of data analyzed. The SNPs genotyped on the array had
previously been subject to extensive validation and yield ge-
notypes with 4 95% accuracy (Tan et al. 2011; Manske et al.
2012). Before we scored CNV at a population scale, we exam-
ined the reliability of all 355,803 CGH probes on our custom
array. We were concerned that unreliable probes could either
limit our ability to detect CNV due to high background signal
or would show an unreasonably high level of false-positive
calls. We hybridized 157 samples to the array, excluded 35
which failed our initial quality control thresholds (supplemen-
tary fig. S2, Supplementary Material online) and examined
variance in probe intensity across the remaining 122 samples.
Probes in hypervariable multigene families (var/rifin/stevor) as
well as clusters of tRNAs, noncoding RNA species, and ribo-
somal RNAs showed significantly increased variance in probe
intensity across samples compared to genome-wide estimates
(fig. 1). While it is likely these gene families harbor abundant
CNV, these results suggest we cannot confidently genotype
these regions using our array technology. In addition, probes
which fell outside exonic regions (<50% of the probe within
an exon) or which contained previously described SNPs
within their sequence showed significant increase in variance
(fig. 1A–E). We therefore excluded probes in these categories.
We performed linear regression of probe intensity against
both probe length and AT content to correct for residual
inconsistencies in probe variance. The decrease in back-
ground signal following our quality filtering is demonstrated
in figure 1F and G and resulted in a mean decrease in variance
of probe intensity of 24.3% (range 0.75–53.5%). Using this
final probe set of 188,081 probes, we segmented the
genome into regions of common intensity using CGHseg.
This probe set covers 5,148 genes, accounting for 11.6 Mb
of the P. falciparum genome.
Reproducibility and Quality Control
To identify appropriate thresholds for determining segments
that exhibit CNV, we sequenced four isolates from this study
using the Illumina HiSeq and Genome Analyzer II platforms.
Previous studies on both humans (Mills et al. 2011) and ma-
laria parasites (Sepulveda et al. 2013) have demonstrated that
calling CNV from sequence data using single methods often
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poorly captures the full extent of variation in a genome. We
called CNVs using three algorithms based on either read
depth (CNVnator (Abyzov et al. 2011) and FREEC (Boeva
et al. 2012)) or read pair distance (BreakDancer (Chen et al.
2009)). We only considered regions retained on the array
following our initial quality filtering. By calling segments
with 8 probes and log2 ratio hybridization signal 4 3 SD
below the mean signal (deletions) or 4 2.5 SD above the
mean (amplifications) as CNVs, 95.7% (114/119) of the CNVs
detected on the array overlap with CNVs detected by one or
more method in the sequence data (supplementary fig. S3,
Supplementary Material online). By varying the threshold
used to call CNVs, we empirically determined these thresh-
olds to be optimal. As the malaria parasite is haploid deletion
results in a complete removal of sequence compared to an
approximate doubling of signal for an amplification. As a
result of this effect, the threshold for amplification and dele-
tion detection is not symmetrical. Finally, to assess the repro-
ducibility of our approach, we examined 11 parasites for
which a total of 24 hybridizations were conducted (2–4
repeat hybridizations per parasite). Using the thresholds de-
termined above, 74.5% of duplications and 88.6% of deletions
(83.7% total) were shared between replicates. Given our high
confidence in CNV calling, this likely reflects the false-negative
rate in our data.
Distribution of CNV within the Parasite Genome
The 122 parasite isolates (of 157 hybridized to our array) that
passed our quality control criteria (supplementary fig. S2,
Supplementary Material online) are described in supplemen-
tary table S1, Supplementary Material online. The global
sample covers the range of malaria transmission intensities
from low (South America: SAM) to intermediate (South East
Asia: SEA) to high (Africa: AFR) with 2–3 countries repre-
sented from each continent.
We robustly scored 134 CNVs within these samples, in-
cluding 33 deletions and 102 amplifications, which encom-
pass 306 partial (n = 171) or complete (n = 135) genes
(supplementary fig. S4 and table S2, Supplementary
FIG. 1. Generating a high-confidence probe set for robust CNV estimation. Distribution of probe level variance (on a logarithmic scale) for the final
probe set (A). The final probe set did not include probes in hypervariable genes (B), ncRNA species (C), probes with 4 1 SNP (D), and nonexonic
probes (E), because these showed extremely high variance. The P values on each histogram show difference in log(variance) for these particular probe
groups relative to other probes within the dataset. Probe level hybridization of a single strain (CAM 11) before (F) and after (G) removal of probes with
high variance. The dotted lines indicate a doubling/halving of signal. Removal of probes showing high variance reduces threshold and improves
sensitivity for calling CNVs in the final probe set.
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Material online). This constitutes 6% of the 5,148 genes tar-
geted by our final probe set. Deletions ranged in size from 346
bp to 57.9 kb (median = 1,587.5 bp) and spanned up to 10
genes, while amplifications measured from 334 bp to 59.3 kb
(median = 1,085.5 bp) and spanned up to 18 genes. Ninety-
seven CNVs (17 deletions and 80 amplifications) were biallelic,
while 38 CNVs (18 deletions and 20 amplifications) showed
clear evidence for multiple alleles (from 3 to 11). For example,
at the CNV containing the multidrug resistance locus (chr 5),
there are six different amplicons ranging from 10.6 to 26.9 kb
and containing from three to six genes, consistent with pre-
vious work using real-time polymerase chain reaction (Nair
et al. 2007). The number of CNVs per chromosome was
strongly correlated with chromosome length (r2 = 0.88; sup-
plementary fig. S4B, Supplementary Material online).
Comparison of CNV between Continents
The burden of CNVs harbored by a genome varied substan-
tially at a continental scale. We measured the burden of CNV
in each continental population using two approaches. First,
we used survival curves (Sudmant et al. 2013). These incor-
porate information on CNV size and allele frequency for pop-
ulation comparisons, so fully utilize the data. The heaviest
burden of deletions was observed in SAM, followed by SEA,
and then AFR. The differences in CNV burden between SEA
and AFR populations were not significant, but both of these
populations show significantly lower levels of deletions
(fig. 2A) than SAM populations (AFR vs. SAM: P = 7.3
 109: SEA vs. SAM, P= 1.9 108, log-rank test).
Continental comparisons of gene amplifications revealed sim-
ilar patterns (fig. 2B), with highly significant increase in am-
plified genome regions in SAM, relative to AFR (AFR vs.
SAM: P = 2.5  105, log-rank test) and SEA (SEA vs. SAM:
P = 1.5 106, log-rank test).
The differences in CNV burden revealed by the survival
analysis stem from underlying differences in the number, size
and allele frequency distribution of CNVs. The number of
deletions (fig. 3A) and amplifications (fig. 3B) show strong
differences between locations. These raw numbers are diffi-
cult to interpret because sample sizes differ between conti-
nents. However, examining mean numbers of CNVs per
sample confirmed a significantly lower number of deletions
per sample in AFR (fig. 3C, mean = 3.15, SD = 1.10) than in
SEA (mean = 4.13, SD = 1.76, P = 1.9 103, W = 1,839.5,
Wilcoxon rank sum [WRS] test) or SAM (mean = 4.64, SD =
1.50, P = 6.3 104, W = 111, WRS test) and that the num-
bers of amplifications in SAM (fig. 3D; mean = 15.00, SD =
13.51) significantly exceeded those observed in both AFR
(mean = 2.70, SD = 3.76, P = 5.3 105, W = 80, WRS test)
and SEA (mean = 2.09, SD = 1.66, P = 7.4 106, W = 122,
WRS test).
SAM populations also contained deletions which were sig-
nificantly longer than either SEA populations (P = 2.6 
106, D = 0.32, Kolmogorov–Smirnov [KS] test) or AFR pop-
ulations (P = 1.3  106, D = 0.36, KS test). Similarly, SEA
populations harbor larger deletions than AFR populations
(P = 0.03, D = 0.13, KS test, fig. 3E). The trend is reversed
for amplifications (fig. 3F) with SAM populations harboring
significantly smaller CNVs than either AFR (P = 0.007, D =
0.20, KS test) or SEA (P = 2.4  105, D = 0.25, KS test) and
no significant difference between AFR and SEA populations
(P = 0.21, D = 0.13, KS test). We were concerned that these
trends in size could be driven by location specific CNVs. We
therefore reanalyzed the data including only CNVs (8 dele-
tions and 11 amplifications) that were present in all three
continents. For each CNV locus, we took the mean CNV size
seen in each continent and compared the distributions of all
CNV loci between continents (fig. 3G). This showed that
CNVs in SAM isolates were significantly longer than those
in either SEA (t = 4.31, P = 1.3 104, t-test) or AFR (t = 4.23,
P = 1.6  104, t-test) and that CNVs in SEA isolates were
longer than in AFR isolates (t = 4.02, P = 2.9  104, t-test).
There was a skew toward rare CNVs (both deletions and
amplifications) in SEA and AFR populations (fig. 4) with ap-
proximately 80% of all variants present at population frequen-
cies of< 10%. However, SAM populations show significantly
less skew and show greater consistency with a neutral popu-
lation structure. We performed coalescent simulations to de-
termine whether the observed CNV allele frequency spectra
in each population differ substantially from neutral expecta-
tions (supplementary fig. S5, Supplementary Material online).
In both SEA (2 = 15.2, P = 4.94  104, 2 test) and AFR
(2 = 8.8, P = 0.0121, 2 test) populations, we can reject
neutrality, though SAM does not show a significant deviation
from a neutral population structure (2 = 2.7, P = 0.257, 2
test). Hence, the increased proportion of high frequency
CNVs in SAM, relative to AFR or SEA, contribute to the
higher burden of both deletions and amplifications in SAM.
Under a deleterious model of CNV evolution, we might
expect longer CNVs to be more deleterious than short CNVs,
so CNV size and frequency should be inversely related. This is
clearly observed for deletions in all continents (P = 2.6 
1025 [SEA], P = 2.9 1010 [AFR], P = 6.9 104 [SAM]).
However, for amplifications a significant negative relationship
was observed for only SEA (P = 9.5 1012), and no trend
was observed in AFR and SAM (fig. 5A and B).
In total, 22 of 30 tests conducted revealed significant dif-
ferences in burden, size, or frequency spectrum of CNVs be-
tween continents. After Bonferroni correction for multiple
testing, this was reduced to 19/30 tests.
Positive Selection on CNVs
Allele Frequency Tests
Given that strong purifying selection appears to act on most
CNVs, CNVs present at high frequency within one or more
populations sampled are strong candidates for positive selec-
tion. We first plotted CNVs by population frequency across
the genome (fig. 5C). Twelve CNVs show frequencies 4 50%
in at least one population. These included pfmdr1, PfRH2b,
and histidine-rich proteins II and III. We then searched for
CNVs showing divergent allele frequencies between popula-
tions by plotting FST across the genome for the three conti-
nental comparisons for both SNPs and CNVs genotyped on
our array. The distribution of the FST values for CNVs and
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SNPs can be described by their quantiles (fig. 6B, D, and F,
open dots). These show that CNVs are skewed toward lower
fixation indices than SNPs between AFR and SEA (AFR: D =
0.42, P = 3.3 1013; SEA: D = 0.26, P = 4.8 107 KS test). In
contrast, comparisons with SAM reveal a smaller, though still
statistically significant, skew in the distribution of FST values
for both CNVs and SNPs (D = 0.20, P = 1.1  104 KS test).
We used the distribution of FST at SNPs for detection of out-
lying CNVs. We calculated FST for CNVs using both biallelic
classification (CNV vs. WT) or by using size of CNVs to define
different alleles (38/135 [28.1%] CNVs had 4 2 alleles). We
used an FST-like statistic (G’ST [Hedrick 2005]) for multiallelic
CNVs (fig. 6, closed dots). This minimizes downward bias in
estimates of differentiation and allows comparison between
binary and multiallelic CNVs. When we included the size of
amplified or deleted regions in FST calculations, we observed a
net change in FST statistics at some loci (mean change = 0.044,
SD = 0.16, fig. 7D).
Using a stringent 95% SNP threshold, we found a single
CNV that was significant in one or more continental com-
parison (PfRH2b, fig. 7). When we relaxed this threshold to
90% (table 1), we identified no additional loci in the AFR-SEA,
3 in the SEA-SAM and 10 in the AFR-SAM comparisons.
Three loci were significant in multiple comparisons. As selec-
tion acting on nonsynonymous SNPs may drive FST signal, we
reanalyzed the data after excluding nonsynonymous variants
from the analysis (supplementary fig. S6, Supplementary
Material online). This resulted in a minor deviation in the
distribution of FST values, though did not alter the inference
of selection acting on any CNVs. A deletion encompassing
reticulocyte binding-like homologue protein 2 (PfRH2b), a key
adhesive molecule involved in erythrocyte invasion, showed
significant FST in both the AFR-SEA and AFR-SAM compari-
sons. Two size variants of this locus are present globally. A
small deletion truncates the coding sequence of PfRH2b,
whereas a larger variant encompasses the PfRH6 pseudogene
upstream of PfRH2b (fig. 7A–C). This locus was significant
with the multiallelic classification (G’ST = 0.89) but not with a
biallelic classification (FST = 0.48) in the AFR-SEA comparison,
demonstrating the importance of defining CNV alleles, rather
than grouping CNV alleles with different origins. The PfRH2b
CNV has been extensively studied and evidence suggests that
it is under strong selection (Jennings et al. 2007; Lantos et al.
2009; Ahouidi et al. 2010). In addition, two loci, a membrane
protein on chr. 9 (PF3D7_0924500) and a conserved gene on
chr. 10 (PF3D7_1027000), show significant FST in both SEA-
SAM and AFR-SAM comparisons.
We conducted a similar FST analysis to compare CNV fre-
quencies from different countries within SEA and AFR (fig. 8;
samples sizes in Peru were too small to do this in SAM). The
SEA comparison is of particular interest because it has the po-
tential to identify CNVs underlying drug resistance. The three
neighboring SEA countries have different histories of antima-
larial drug treatment (Anderson, Nair, Sudimack, et al. 2005),
and as a consequence, parasite populations differ in the prev-
alence of drug resistance mutations (Nair et al. 2003, 2007,
2008; Nash et al. 2005; Cheeseman et al. 2012). Both Thailand
and Cambodia show wide-spread resistance to multiple
antimalarials, whereas Laos populations still retain parasites
that are sensitive to all drugs including chloroquine (Mayxay
et al. 2007). There were six CNVs in the 90th percentile of SNP
FST in comparisons between SEA countries and one CNV in
the Malawi–Gambia comparison (table 2). As expected, am-
plification of the multidrug resistance gene (pfmdr1) on chr 5
showed the highest FST in comparisons between Thai and
Laos parasite populations. pfmdr1 is a well-studied locus
that is known to be under strong selection (Nair et al.
2007) (fig. 5). PfRH2b also showed highly significant FST in
the Thai–Laos comparison, while we found elevated FST in the
Cambodian–Thai comparison at a deletion containing
clag3.1/3.2, genes that determine channel-mediated nutrient
uptake by infected red blood cells (Nguitragool et al. 2011)
and play a role in blastocidin resistance (Sharma et al. 2013).
Haplotype Tests
We explored whether strong, recent, positive selection is
driving the spread of CNVs using two approaches. First, we
FIG. 2. CNV burden differs between parasite populations from different continents. Survival curves compare the relationship between CNV burden and
proportion of parasites affected for both amplifications (A) and deletions (B). For each population, central line shows the mean, while the outer lines
represent 95% CI. There is a significant excess of CNV in South American populations for both amplifications and deletions.
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measured the integrated haplotype score (iHS) and cross-
population extended haplotype homozygosity (XP-EHH)
across the genome, treating SNPs and CNVs as equivalent
biallelic markers (supplementary figs. S7 and S8,
Supplementary Material online). A single CNV (surfin 14.1)
in AFR ranked in the top 5% of iHS scores genome wide,
while no CNVs ranked in the top 5% of XP-EHH. The chr. 5
amplification containing pfmdr1 is known to be under strong,
FIG. 3. CNV abundance and size contributes to continental trends in CNV burden. (A, B). Numbers of CNVs observed. CNVs that are shared between
continents contain at least one gene in common but may differ in size and have independent origins (fig. 9). (C, D) Plots showing CNV burden per
isolate reveal significant differences in the numbers of both deletions and amplifications between continents. (E, F). Size of CNVs per isolate. There are
significant differences in the mean size of CNVs, but the patterns observed differ for deletions and amplifications. Frequency distributions of CNVs
stratified by size are shown in figures 5 and 9. (G) Size of 19 CNVs common to all three continents. *P < 0.05, **P < 0.01, ***P < 0.001.
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FIG. 5. The relationship between size and frequency of CNVs. (A, B) A negative relationship between size and frequency is seen for deletions but only in
SEA for amplifications. (C) Twelve CNVs were at 4 50% frequency in at least one population. Three of 12 (25%) are known targets of positive selection
(eba175, pfmdr1, PfRH2b), whereas 7/12 (58%) show high FST/G’ST (marked by asterisk; see figs. 6 and 8).
FIG. 4. Allele frequency distribution of (A) deletions and (B) amplifications. Allele frequency distributions differ between continents. These distributions
fit a neutral model in SAM but not in AFR or SEA (see supplementary fig. S5, Supplementary Material online).
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recent selection due to its role in mefloquine resistance but was
not captured in this genome scan using either statistic. Second,
we used a more targeted approach, in which we compared the
decay in haplotype homozygosity for the different CNV alleles
at each of the putatively selected loci identified from the G’ST/
FST analysis. Our inability to identify selection using long hap-
lotypes surrounding CNVs may have been limited by recurrent
mutation of CNVs on different haplotypes. Such a scenario
would severely limit the power of haplotype-based tests of
selection (Messer and Petrov 2013). We examined EHH sur-
rounding each size delimited allele of a CNV under selection
(supplementary fig. S9, Supplementary Material online). We
saw little distinction between haplotype decay of individual
pfmdr1 amplicons. This is consistent with previous work,
which showed similarly sized amplicons have arisen on distinct
haplotypic backgrounds (Nair et al. 2007). At other loci, direct
measurement of EHH on size-resolved CNVs did not suggest
recent adaptation has acted on any of the CNVs we have
identified. We additionally examined if excluding SNP markers
which may be subject to selection (nonsynonymous SNPs)
altered our ability to identify CNVs with significant iHS
scores (supplementary fig. S10, Supplementary Material
online). As nonsynonymous SNPs comprise 5,494 of the
10,107 SNPs (53.7%), there was a substantial decrease in
marker density. However, exclusion of these SNPs had no
impact on the inference of selection acting upon CNVs.
Discussion
Validation of a Robust Call Set of CNVs
The P. falciparum is extremely AT rich, with highly repetitive
telomeric regions containing several multigene families,
making it challenging for both sequence alignment
(Manske et al. 2012) and analysis of CNVs. We opted to
remove problematic regions of the genome from our analysis,
to decrease background signal and maximize robustness and
repeatability of CNV calling elsewhere in the genome. To this
end, we carefully evaluated the extent to which specific ge-
nomic features are likely to affect the detection of CNV. By
excluding genome regions which exhibit unreliable hybridiza-
tion signal and applying suitable correction factors (regression
against probe AT content and length), we were able to min-
imize the error rate. However, in doing so, we have limited our
analysis to exonic genome regions and excluded gene families,
which may possess a high level of CNV. Noncoding regions of
eukaryotic genomes have been shown to contain a higher
burden of CNV than coding regions (Mills et al. 2011),
though the extreme AT content in the malaria parasite
(Gardner et al. 2002) genome preclude their analysis here.
Similarly, the pfemp1 (orvar) gene family and the rifin and
stevor gene families have been suggested to harbor extensive
CNV (Freitas-Junior et al. 2000). However, the combination of
strong homology among conserved regions of the genes and
FIG. 6. FST identifies putative targets of natural selection at a continental level. Genome-wide FST for all biallelic SNPs (pink/light blue dots) and CNVs
(red/blue dots) for AFR versus SEA (A), SEA versus SAM (C), and AFR versus SAM (E). The dotted line shows the 90% and 95% thresholds. Open dots are
FST calculated from binary classification of CNV, while closed dots utilize CNV size information (G’ST). The joint distribution of FST for SNPs (y axis) and
CNVs (x axis) is shown by quantile–quantile plots (B,D,F). If the distribution of FST for CNVs and SNPs is equivalent (as could be expected under
neutrality), points should lie along the diagonal dash line.
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extensive diversity throughout variable regions (Kyes et al.
2007) makes precise determination of CNV within these com-
plex gene families problematic. Including probes targeting
these gene families increases the background probe variation
and therefore obscures detection of biologically relevant var-
iation elsewhere in the genome. The resolution of our CNV
calling (segments of 8 probes) puts a practical lower limit
on the size of variants we can detect of approximately 500 bp.
FIG. 7. Deconvolution of the PfRH2b locus results in clearer evidence of selection. (A) Normalized, probe level signal from three representative
hybridizations. Boundaries for calling CNVs are shown by dashed lines. THA 22 (blue dots) contains no CNV, while both GAM 18 (AFR) and
CAM 11 (SEA) exhibit CNV. The deletion for CAM 11 is larger (5.9 kb vs. 0.5 kb) and includes the neighboring gene, pfRH6. (B) Probe signal at this
locus for all 122 isolates. Darker blue denotes decreasing probe signal. (C) Size variants of the PfRH2b deletion in SEA and AFR, showing difference in
size of the deletion present on each continent. No CNV at this locus was seen in SAM. (D) Incorporation of CNV size information refines analysis
of selection. When CNV size information is incorporated, a net reduction in FST is seen. However, we see an increase in FST at the PfRH2b locus between
AFR and SEA.
Table 1. Summary of CNV Burden in Different Parasite Populations.
Country Continent n Number of CNVs CNVs per Parasite No. Genes Affected/Parasite
Amp Del Amp Del Amp Del
The Gambia AFR 25 38 13 3.60 3.80 5.08 7.88
Malawi AFR 15 8 14 1.27 4.67 1.33 12.33
AFR 40 46 27 2.73 4.13 3.68 9.55
Thailand SEA 25 6 18 2.24 5.64 4.64 15.48
Laos SEA 28 30 24 2.43 4.71 3.17 11.57
Cambodia SEA 15 12 17 2.60 5.60 4.07 13.67
SEA 68 48 59 2.40 5.25 3.91 13.47
Venezuela SAM 12 59 14 13.25 6.17 17.92 28.67
Peru SAM 2 48 5 29.00 4.50 32.5 13.00
SAM 14 107 19 14.47 5.53 20.00 26.43
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Previous genome sequencing studies have identified rampant
variation in human genomes in the 0–500 bp region (Mills
et al. 2011), and further sequencing efforts will be required to
elucidate the full spectrum of variation in parasite genomes.
However, by limiting the variation we explore in this article to
high-confidence polymorphisms, we can make inferences
about arguably the most interesting component of the ge-
nome coding sequence. These are likely to be both highly
visible to both purifying and positive selection and are phe-
notypically relevant.
Many CNVs Are Subject to Strong Purifying Selection
Two features of this data set suggest that CNVs tend to be
deleterious and subject to strong purifying selection. First, the
distributions of CNVs are strongly skewed toward low fre-
quency variants, particularly in AFR and SEA populations
(fig. 4, supplementary fig. S5, Supplementary Material
online). Second, for deletions, there is a strong negative
correlation between deletion size and population frequency
(fig. 5A and B). This pattern is most likely observed because
loss of several genes is more likely to have deleterious impact
than loss of a single gene. That this correlation is not seen for
amplifications suggesting that selection against this class of
CNV is less restrictive.
There are several reasons why CNVs may be under parti-
cularly strong purifying selection in malaria parasites relative
to diploid organisms. First, deletions in essential genes will
result in death of haploids, but deleterious deletions can be
maintained in heterozygous state in diploids. Similarly, ampli-
fications are expected have stronger dosage effects in haploids
than diploids because gene duplication results in 2-fold
change in haploids (1!2 copies), while amplification of a
single gene copy results in 1.5-fold change (2!3 copies) in
diploids. There is strong empirical evidence that gene dosage
results in dramatic genome wide change in transcription pat-
terns from an eQTL study of P. falciparum (Gonzales et al.
FIG. 8. FST identifies putative targets of natural selection in SE Asia. Genome-wide FST for all biallelic SNPs (pink/light blue dots) and CNVs (red/blue
dots) for CAM versus THA (A), CAM versus LAO (C), THA versus LAO (E), and GAM versus MAL (G). The dotted line shows 90% and 95% thresholds.
Open dots are FST calculated from binary classification of CNV, while closed dots utilize CNV size information. For the joint distribution of FST for SNPs
(y axis) and CNVs (x axis) is shown by quantile–quantile plots (B,D,F,H). If the distribution of FST for CNVs and SNPs is equivalent (as could be expected
under neutrality), points should lie along the diagonal dash line.
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2008). Forty-eight percent of expression quantitative trait loci
(eQTLs) identified mapped to the chr 5 CNV containing
pfmdr1, suggesting that this CNV has risen to high frequency
in SE Asian countries due to extremely strong drug selection
despite extensive perturbation of the parasite transcriptome.
Greater Burden of CNVs in South America: Impact of
Parasite Demography
A striking feature of these data is that SAM parasites carry a
larger burden of CNVs than parasites from SEA or AFR. This
contrasts with diversity measured using SNPs and microsat-
ellites, which universally demonstrate reduced variation in
SAM parasite populations (Anderson et al. 2000). Each of
the continental populations used in our dataset differs in
key epidemiological parameters. The effective population
size, recombination rate, outcrossing rate, and mean clonality
of infections are all highest in AFR and lowest in SAM
(Conway et al. 1999; Anderson et al. 2000) and show an in-
verse relationship to CNV burden (fig. 2). We see a similar
scaling of CNV size by continental origin (fig. 3E–G), a result
we demonstrate is unlikely due to any specific bias of CNV
frequency or CNV burden. Coupled with our analysis of the
relationship between CNV size and CNV frequency (supple-
mentary fig. S5, Supplementary Material online), this provides
support for a model where CNVs are generally under strong
purifying selection. As the strength of purifying selection
scales with Ne, settings where Ne is reduced (such as SAM)
have a reduced ability to purge deleterious CNVs from the
population. While in SEA and AFR, we see a skew toward
more rare variants than expected under neutrality (supple-
mentary fig. S5, Supplementary Material online), no clear
deviation is seen for SAM populations. This model is also
supported by forward simulations of a locus under weak pu-
rifying selection in populations with different Ne (supplemen-
tary fig. S11, Supplementary Material online). The trajectory of
a weakly deleterious mutation in a large population is largely
deterministic and rapidly driven to lower frequencies, while
smaller populations maintain deleterious variants for longer
periods, and these may drift to higher frequency. These sim-
ulation results demonstrate that the differences in Ne ob-
served in malaria parasite populations are sufficient to
explain the differences in CNV burden, size, and distribution
between populations.
The patterns observed in malaria parasites are consistent
with those observed in studies of the impact of demography
on the distribution of deleterious SNP alleles in human pop-
ulations. A high incidence of recessive diseases is found in
populations that have passed through recent bottlenecks
such as Finns and Ashkenazi Jews (Savukoski et al. 1998;
Aaltonen and Bjorses 1999; Aminoff et al. 1999) compared
to other European populations. Similarly, on a genome-wide
scale, Finnish populations show fewer SNPs overall than non-
Finnish European populations, but they show higher frequen-
cies of loss-of-function variants and complete gene knockouts
than non-Finnish Europeans (Lim et al. 2014). Comparison of
African American and European American populations is also
informative. A large exome sequencing study revealed that
European Americans have a large excess of deleterious vari-
ants in essential and Mendelian disease genes compared to
African Americans, consistent with weaker purifying selection
resulting from smaller Ne in European American ancestral
and/or founder populations (Fu et al. 2013).
Table 2. Putative Positively Selected CNVs.
Chr bp coordinates Annotated gene products Significant FST/G’ST comparison
a
2 140118–141161 Zinc finger protein, putative AFR-SAM (0.57/0.38)
3 120415–139753 CLAG3.1, pfemp1 psuedogene, unspecified product, CLAG3.2 CAM-THA (0.23/0.32)
5 948900–975827 Zinc finger protein, pfmdr1, mitochondrial processing pepti-
dase alpha, conserved (x2), DnaJ protein
THA-LAO (0.56/0.50), CAM-THA (0.19/0.36)
7 1360407–1360753 Erythrocyte binding antigen 175 AFR-SAM (0.41/0.56)
8 1367471–1409406 Hsp70, PHISTa (x6), hrpII, stevor (x3), rifin (x2) GAM-MAL (0.24/0.47)
9 64226–111135 Exported protein, rifin (x3), stevor, hyp5, FIKK family 9.1-9.6) AFR-SAM (0.64/0.37)
9 240027–242283 Nucleoporin NUP100/NSP100 THA-LAO (0.28/0.29)
9 995139–997635 Conserved membrane protein AFR-SAM (0.60/0.71), SEA-SAM (0.76/0.78)
9b 1203015–1204856 Msp1 CAM-LAO (0.39/0.30)
10 1129510–1131338 Conserved protein SEA-SAM (0.79/0.65), AFR-SAM (0.56/0.57)
11 284415–286834 Protein kinase SEA-SAM (0.79/0.56)
11 1181887–1183059 Structural maintenance of chromosome protein, putative AFR-SAM (0.47/0.56)
11b 1934717–2003128 Ag332 THA-LAO (0.15/0.22), CAM-THA (0.24/0.43)
12 501013–502183 DNA helicase MCM8, putative AFR-SAM (0.64/0.54)
12 1359123–1359544 Conserved protein AFR-SAM (0.56/0.50)
13 110177–121725 Exported protein (x2), gamete antigen 27/25 AFR-SAM (0.56/0.40)
13 1424351–1430263 Reticulocyte binding protein 2 homologue b AFR-SEA (0.48/0.89), AFR-SAM (0.75/0.94), THA-
LAO (0.44/0.51), CAM-THA (0.15/0.24)
NOTE.—These CNVs fell above the 90% threshold for genome-wide SNP comparisons in pairwise comparisons between continents or countries within continents. FST values are
presented after size classification.
aComparisons significant at the 95% threshold are underlined.
bThese loci are included but have intragenic repeat expansions rather than classical CNVs. They are included here for completion.
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We suggest that differences in Ne provide a likely explana-
tion for the observed patterns, but this is not the only possible
explanation. Several key population parameters covary with
transmission intensity and Ne in Plasmodium. For example, in
low transmission settings, parasite gametes of the same ge-
notype typically fuse and recombine within the mosquito,
resulting in high levels of inbreeding, while outbreeding is
more common in high transmission regions (Anderson
et al. 2000). One alternative explanation for the high
burden of large CNVs in SAM is that these cannot be effi-
ciently purged from populations by recombination. Similarly,
selection regimes experienced by parasites differ in high and
low transmission settings and differences in CNV burden
could be driven by adaptation. Parasites are under strong
drug selection in low transmission regions because patients
are usually symptomatic and seek treatment, while in Africa,
drug selection is weak because most infected people are
asymptomatic and do not seek treatment. We think this ex-
planation is unlikely, because 1) most CNVs are rare, 2) we
found rather few high frequency CNVs consistent with pos-
itive selection, 3) SEA and SAM populations are both exposed
to strong drug selection but show strong differences in CNV
burden, and 4) removal of known CNVs associated with drug
resistance did not alter the genome-wide patterns observed.
Positive Selection Acting upon CNVs
If purifying selection acts strongly against most CNVs in ma-
laria parasites, this suggests that CNVs which have risen to
high frequency (Aminetzach et al. 2005), or those that show
divergent allele frequencies in different countries, may be sub-
ject to positive selection. Our study reveals 12 CNVs that have
risen to 4 50% in any one parasite population. Furthermore,
we found just 11 CNVs showing significant intercontinental
FST and 7 showing significant intracontinental FST. Several of
the CNV loci show independent evidence for positive selec-
tion in previous studies and provide useful positive controls.
These include a well-studied amplification on chr. 5 contain-
ing pfmdr1 (chr. 5), which underlies resistance to several an-
timalarial drugs (Nair et al. 2007), and the reticulocyte binding
protein 2 homolog b (PfRH2b), which is involved in parasite
invasion of erythrocytes (Rayner et al. 2000; Duraisingh et al.
2003). Another gene amplification on chr. 12 containing the
GTP cyclohydrolase I gene is also known to be under strong
positive selection and plays a role in evolution of antifolate
resistance (Nair et al. 2008; Heinberg et al. 2013; Kumpornsin
et al. 2014). This locus was not detected in our survey, but the
reason is technical. The 3D7 parasite which we used as a
reference for all our hybridizations has 4–5 copies of this
amplification, so we were unable to score this CNV in our
population samples.
The rapid spread of beneficial CNV alleles is expected to
result in detectable genomic signatures in the form of long-
flanking haplotypes. Our analyses failed to detect such signa-
tures. First, when we examined genome-wide plots of haplo-
type tests (iHS, XP-EHH) just one CNV (containing surfin 14.1)
fell in the top 5% of values for iHS and none for XP-EHH.
Second, we found no significant differences in haplotype
length surrounding CNV and wild-type alleles. We suggest
two reasons why haplotype tests may perform poorly for
detecting selection around CNVs. First, long-haplotype tests
(such as the iHS and XP-EHH tests used here) are based on the
classical “hard sweep” model of Maynard–Smith (Smith and
Haigh 1974; Sabeti et al. 2002). A key assumption is that mu-
tation is rare, so beneficial mutations have a single origin and a
single long haplotype will hitchhike with the beneficial mu-
tation. This is a weak assumption when mutation rate is high,
as is expected for CNVs (Lipinski et al. 2011), and when pop-
ulations are large, as for microbial pathogens such as malaria
(Pennings and Hermisson 2006; Pritchard et al. 2010). In this
case, multiple independent origins of beneficial CNVs are ex-
pected, so long-haplotype tests will be underpowered. There
is strong empirical evidence that beneficial gene amplifica-
tions have multiple independent origins in malaria parasites
(Nair et al. 2007, 2008). Five to 15 independent origins of
pfmdr1 amplification are recorded in a single Thai location
and have created a “soft sweep” surrounding this gene
(Pennings and Hermisson 2006; Nair et al. 2007), while
three independent origins of GTP-cyclohydrolase I amplifica-
tions were observed in the same population (Nair et al. 2008).
Interestingly, of the CNVs reaching over 50% frequency in any
sampled population, 8/12 (66.7%) had amplicons (or dele-
tions) that differed in size and gene content, consistent
with independent origins. For example, we classified pfmdr1
amplicons by their target sequence and detected 6 amplicons
(10–24 kb in length) each found in 1–9 parasites (fig. 9, sup-
plementary fig. S9, Supplementary Material online).
A second characteristic of CNVs may also complicate the
use of long haplotype tests. Unlike point mutations, gene
amplifications are easily reversible. As a consequence, bene-
ficial duplications may spread within populations but then
back-mutate to single copy status. As consequence, long
haplotype may be associated with both duplications and
single copy genes. We see evidence that this occurs for
both GTP-cyclohydrolase I and pfmdr1 (Nair et al. 2007;
Anderson et al. 2009). These results suggest caution when
using long haplotype tests for implicating CNV as the target
of positive selection.
Materials and Methods
Collection of Malaria Parasites and Preliminary
Genotyping
We obtained parasite-infected blood from P. falciparum-in-
fected patients from three countries in Asia (Thailand, Laos,
and Cambodia), from two countries in Africa (Malawi and the
Gambia), and from two countries in South America
(Venezuela and Peru) (supplementary table S1,
Supplementary Material online). In each location, we col-
lected 6–10 ml blood from patients with 4 0.5% parasite
density to provide sufficient parasite DNA for genetic charac-
terization, and patients coinfected with other Plasmodium
species were excluded. After removal of the buffy coat,
DNA was extracted using the phenol-chloroform method
and parasite DNA concentrations estimated by real-time po-
lymerase chain reaction of the ama-1 parasite gene. All
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samples fell within acceptable limits of human DNA contam-
ination empirically determined in Tan et al. (2011).
Parasite isolates were prescreened for multiple infections
and identical clones using previously collected genotype
data. Thailand, Laos, and Malawi samples were genotyped
using seven polymorphic microsatellite markers (ARA2 (chr
11), POLY (chr 4), TA1 (chr 6), C2M1 (chr 2), C3M54 (chr
3), TA60 (chr 13), and C4M30 (chr 4), which were amplified
and scored on a capillary sequencer (Anderson, Nair, Qin,
et al. 2005). Cambodian samples were genotyped with 18
microsatellite loci (Anderson et al. 2010). South American
samples were genotyped for 96 SNPs using the Veracode
platform (Illumina) (Phyo et al. 2012), whereas Gambian
samples were genotyped with two highly polymorphic an-
tigen loci (Merozoite surface antigens 1 and 2) (Snounou
et al. 1999). These preliminary genotyping data enabled us
to 1) to identify and exclude infections containing more
than one parasite genotype. Such multiple genotype infec-
tions (MGI) are particularly common in African and Asian
locations and preclude accurate genotyping of parasite hap-
lotypes. 2) To identify genetically indistinguishable infec-
tions in different patients. These parasite clones occur
frequently in populations with low transmission where self-
ing between male and female parasites from the same in-
fections occurs (Anderson et al. 2000, 2010; Echeverry et al.
2013). To minimize relatedness in our sample, we retained
one parasite genotype from each clonal group.
Ethics Statements
We obtained written informed consent from all participants
in this study. In the case of minors, the parents or guardians
gave consent prior to enrollment. Consent procedures, study
protocols, and collection of malaria-infected blood samples in
each country was approved by the appropriate national and
international ethics review boards as follows:
The Gambia: The Gambia Government and MRC Joint
Ethics Committee, and the Ethics Committee of the
London School of Hygiene and Tropical Medicine.
Malawi: College of Medicine Research and Ethics
Committee, University of Malawi.
Thailand: Ethics Review board of the Faculty of Tropical
Medicine, Mahidol University.
Cambodia: Ministry of Health in Cambodia, the Oxford
Tropical Medicine Ethical Committee, the World Health
Organization (WHO) Research Ethics Review Committee,
and the Technical Review Group of the WHO Western
Pacific Regional Office.
Laos: The National Ethics Committee for Health Research,
Ministry of Health, Laos.
Peru: The Institutional Review Boards at New York
University, the Peruvian Ministry of Health Institutes of
National Health, and the University of Alabama at
Birmingham.
Venezuela: The committee on bioethics and biosafety of
the Institute for Research in Biomedicine and Applied
Sciences (IIBCA), Universidad de Oriente.
Comparative Genomic Hybridization
These isolates were then hybridized to a custom Nimblegen
SNP-CNV genotyping array (Tan et al. 2011) following stan-
dard Nimblegen CGH protocols. The array contains 364,192
probes which interrogate 45,524 SNP loci, as well as 50–
75 bp cGH probes tiled through the genome. Use of a mi-
croarray, rather than Illumina sequencing, allowed us to ex-
amine parasite infections with substantial amounts
(4 95%) human DNA contamination. To accommodate
the extreme nucleotide bias in the P. falciparum genome
(Gardner et al. 2002), 65% AT cy3 and cy5-labeled random
nonamers were used to fluorescently label target DNA.
Genotype calls were performed as in Tan et al. (2011), and
the data were cleaned to remove loci with 4 20% missing
data and a minor allele frequency of< 5%. The accuracy of
SNP typing for this platform have been previously tested
(Tan et al. 2011; Cheeseman et al. 2012; Manske et al.
2012). CNV calling was performed by segmenting the
genome using CGHseg using default settings and classifying
gains and losses as regions which had 4 8 probes and had a
log 2 ratio (cy3/cy5) 4 2.5 (for amplifications) or 3 (for
deletions) times the standard deviation of the underlying
probe level data. Prior to analysis probes on the array were
remapped to PlasmoDB version 9.2 of the 3D7 reference
strain (http://plasmodb.org/common/downloads/release-9.
2/Pfalciparum3D7/fasta/data/, last accessed December 11,
FIG. 9. The relationship between CNV frequency and the number of alleles at a locus. We see a positive correlation between the frequency of a CNV and
the number of size polymorphisms observed in that CNV for African (A), SE Asian (B), and South American (C) populations.
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2015) using BLAST v2.2.27 where best perfect hits were re-
tained for each probe.
CNV Calling from Next-Generation Sequencing
Genome sequences of four Thai isolates, that were genotyped
on the microarray, were generated as part of a recent, large-
scale resequencing effort (Manske et al. 2012). We aligned
short reads from each of these to PlasmoDB v9.2 of the 3D7
genome using bwa (v0.6.1) and generated sorted indexed
.BAM files using samtools (v0.1.18), and these were used as
an input to CNV calling programs. Each CNV calling algo-
rithm was run with default parameters except for the follow-
ing changes: FREEC v6.0 window size = 200 bp, quadratic
polynomial for GC regression, ploidy = 1, min expected
GC = 0.05, max expected GC 0.5, CNVnator v0.2.7 bin size =
200. Parameters for BreakDancer v1.1.2 were calculated using
the bam2cfg.pl script included in the BreakDancer distribu-
tion). We excluded CNVs which fell outside the genome re-
gions called by the array using Bedtools v2.17.0 and
additionally filtered out CNVs < 500 bp long and amplifica-
tions with a copy number of< 4 (FREEC), a median ratio
of 4 1.75 (amplifications) or< 0.5 (deletions) and a q0
of 4 0.5 (CNVnator) and structural variations which were
not classified as either deletions or insertions (BreakDancer).
Statistical and Population Genetic Analysis
All statistical analysis were performed in R v3.0.2 except for FST
analysis which was performed in R2.6.2 using the hierfstat
package (GOUDET 2005). G’ST was calculated using the
SMOGD v.1.2.5 software (Crawford 2010). Significant FST
values for CNVs were determined by taking the FST distribu-
tion of SNPs as a null distribution and scoring CNVs which fell
outside of the 95th percentile as significant. Kolmogov–
Smirnov and t-tests were two tailed and performed using
the stats package. Survival analysis of CNVs was performed
using the Survival package.
Neutral allele frequency spectra were generated using
msms v3.2. following Cridland and Thornton (2010) using
the options -ms Nchr Nreps –t w –s Segsites -oAFS, where
Nchr is the number of chromosomes simulated (equal to the
sample size: 40,68,14), Nreps is the number of simulations to
perform (1,000), w is Watterson’s theta and Segsites is the
number of segregating sites in the population. The allele fre-
quency spectra were output for comparison to actual data.
Data Access
Array data have been submitted to the NCBI Gene Expression
Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/, last
accessed December 11, 2015) under accession numbers
GSE75137.
Supplementary Material
Supplementary figures S1–S11, data set S1, and tables S1 and
S2 are available at Molecular Biology and Evolution online
(http://www.mbe.oxfordjournals.org/).
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